前药
荧光
化学
双光子激发显微术
生物物理学
硫化氢
内生
荧光寿命成像显微镜
药品
体内
生物化学
药理学
生物
有机化学
量子力学
物理
生物技术
硫黄
作者
Xianghua Wu,Yuxun Lu,Bo Liu,Yu Chen,Junfeng Zhang,Ying Zhou
标识
DOI:10.1016/j.cclet.2021.02.065
摘要
We designed and synthesized a ratiometric fluorescent prodrug capable of releasing active therapeutic component while detecting hydrogen sulfide. Hydrogen sulfide (H 2 S) is a signaling molecule that plays important roles in biological systems. The exploration of H 2 S as a new drug release trigger and its related fluorescent theranostic system is crucial for cancer bio-imaging and therapy. Herein, we designed a new two-photon ratiometric fluorescent theranostic prodrug (compound 1 ) and studied its spectroscopic properties and application in in vivo imaging. Compound 1 specifically reacted with H 2 S and released the free active therapeutic component of 7-ethyl-10-hydroxycamptothecin, which was accompanied with a red-shift fluorescence emission signal from 460 nm to 545 nm. The exogenous and endogenous H 2 S in living cells were imaged by compound 1 under one-photon and two-photon excitation. Furthermore, compound 1 monitored the H 2 S concentration changes in Caenorhabditis elegans by fluorescence imaging. Additionally, it showed effective drug release activation in situ tumor with exogenous and endogenous H 2 S as the trigger. The H 2 S-sensitive activation and drug-release properties highlight the potential of theranostic compound 1 in future cancer treatment and therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI